Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,38 USD | -0,72% |
|
-2,13% | -17,37% |
Attività
Numero di dipendenti: 47
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cardiovascular Medicines
100,0
%
| 5 | 100,0 % | 1 | 100,0 % | -80,00% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 5 | 100,0 % | 1 | 100,0 % | -80,00% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 07/03/17 |
Amit Hasija
DFI | Director of Finance/CFO | 51 | 09/09/19 |
Anita Holz
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Chief Tech/Sci/R&D Officer | - | 01/11/21 | |
David Bharucha
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/02/22 |
Jeff Nelson
COO | Chief Operating Officer | 42 | 01/06/20 |
Kimberly Sheehan
HRO | Human Resources Officer | - | 01/04/22 |
Roshan Girglani
SAM | Sales & Marketing | - | 01/08/22 |
Lorenz Muller
PRN | Corporate Officer/Principal | 60 | 01/10/17 |
Guy Rousseau
LAW | General Counsel | - | 01/01/16 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Seth Fischer
BRD | Director/Board Member | 68 | 21/03/23 |
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 07/03/17 |
Debra Liebert
BRD | Director/Board Member | 67 | 01/06/15 |
Director/Board Member | 75 | 11/11/19 | |
Michael Tomsicek
BRD | Director/Board Member | 58 | 01/04/19 |
Lisa Giles
BRD | Director/Board Member | 65 | 01/10/20 |
Robert Wills
CHM | Chairman | 70 | 01/10/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 53 260 467 | 52 890 840 ( 99,31 %) | 0 | 99,31 % |
Coordinate società
Milestone Pharmaceuticals, Inc.
1111 Dr. Frederik-Philips Boulevard Suite 420
H4M 2X6, Montréal
+
http://www.milestonepharma.com![Indirizzo Milestone Pharmaceuticals Inc.(MIST)](https://cdn.zonebourse.com/static/address/58002404.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-17,37% | 91,29 Mln | |
+15,19% | 121 Mrd | |
+19,91% | 114 Mrd | |
+8,24% | 23,61 Mrd | |
-19,80% | 20,43 Mrd | |
-16,19% | 16,55 Mrd | |
-13,45% | 16,45 Mrd | |
-44,35% | 15,59 Mrd | |
+66,67% | 15,19 Mrd | |
+2,13% | 13,54 Mrd |
- Borsa valori
- Azioni
- Azione MIST
- Società Milestone Pharmaceuticals Inc.